Benelux Infrastructure Forum

Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home topics Health What I need to know about Biosimilar Medicines - Information for patients

What I need to know about Biosimilar Medicines - Information for patients

29 November 2017, 18:15 CET
— filed under:

The European Commission launched today additional translations of the Q&A paper “What I Need to Know about Biosimilar Medicines – Information for patients’’ making it available now in 23 official European languages, in order to provide patients with easy-to-understand information about biosimilar medicines. What are biosimilar medicines? How are they produced? How are they approved? Are they safe? – These questions and many more are addressed in this paper. Empowering patients to engage, discuss and participate in decisions on their treatment options is key to improving patient outcomes and contributing to the effective treatment of their individual condition(s).

The link address is: http://ec.europa.eu/growth/content/consensus-information-biosimilars-23-languages_en

Document Actions